Search
for
Sort by
Research 241–270 of 661
- Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women<sup>1</sup>
- Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight
- What are the possible reasons for urethral PSA varieties after radical prostatectomy?
- Efficacy of <i>Serenoa repens</i> lipido-sterolic extract alone or in combination with propolis polyphenols and <i>Boswellia serrata</i> extract suppositories on PSA level and symptoms in patients affected by lower urinary tract disorders
- Phase I-II trial of weekly bicalutamide in men with high PSA and negative biopsy
- PSA Test Sensitized by Finasteride
- 5ARI and PSA: open questions
- 1262 ONE YEAR FINASTERIDE THERAPY IN MEN WITH A SERUM PSA GREATER THAN 4 NG/ML WHO HAD UNDERGONE REPEAT BIOPSY
- S2 PSA: RELIABLE OR NOT RELIABLE?
- S90 Urethral PSA production after radical prostatectomy
- Impact of baseline PSA level on quality of life measures of general health and sexual satisfaction/drive in men with BPH treated with finasteride or placebo
- MP31-04 HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE?
- S4 URETHRAL PSA LEVELS AFTER RADICAL PROSTATECTOMY
- PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY
- PSA concentration change in men taking low dose finasteride and dutasteride for male androgenetic alopecia
- Efeitos do uso da finasterida sobre o volume prostático e dosagem sérica do PSA em pacientes jovens
- Effects of the use of finasteride on prostate volume and serum PSA in young patients
- UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia?
- FINASTERIDE AND PSA
- A Review on the Clinical Utility of PSA in Cancer Prostate
- Atherogenesis: Estrogen Induction of Polysialylated nCAM (PSA-nCAM) Blocks Monocyte Capture by Vascular Endothelial Cells
- Επικύρωση της χρησιμότητας των νεότερων παραμέτρων του PSA ορού για την ανίχνευση του καρκίνου του προστάτη
- 42134 Long-term Efficacy of Guselkumab (GUS) on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study in Biologic-naïve Patients With Psoriatic Arthritis (PsA)
- The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men
- The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study
- Urinary Retention in Patients with BPH Treated with Finasteride or Placebo over 4 Years
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- Acute urinary retention: risks and management.
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer